Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

The Delhi High Court on Wednesday directed the Central Drugs Standard Control Organisation (CDSCO) to decide, within 3 months ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by rising obesity and type 2 diabetes incidences, the ...

GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.

Delhi High Court asks DCGI to consult experts on weight-loss drug combinations, addressing concerns over safety and approval ...

Multimodal AOMs were associated with the highest preoperative weight loss among patients with high BMI undergoing bariatric surgery.

I was just a baby scientist when I discovered the hormone that made Ozempic possible. I had no idea how life-changing—and world-changing—that ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

UK health authorities are investigating pancreatitis cases linked to weight-loss drugs like Ozempic and Mounjaro. We spoke to doctors for clarity on risks, side effects, and the role of genetics.

Obesity costs U.S. health care nearly $173 billion yearly. With more than 200 related complications such as heart disease, ...

Israel: A new study published in JAMA Network Open highlights a key safety insight for patients with type 2 diabetes taking ...